Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology